Clinical Trials Logo

Biventricular Failure clinical trials

View clinical trials related to Biventricular Failure.

Filter by:
  • None
  • Page 1

NCT ID: NCT06174103 Not yet recruiting - Heart Failure Clinical Trials

BiVACOR® Total Artificial Heart Early Feasibility Study

Start date: March 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the feasibility of using the BiVACOR Total Artificial Heart (TAH) System to support adult patients with severe biventricular heart failure, or univentricular heart failure in which left ventricular assist device (LVAD) support is not recommended, who require mechanical circulatory support to sustain life. The BiVACOR TAH System is intended for use as a bridge to transplant (BTT). Feasibility will be assessed by evaluating safety and performance of the BiVACOR TAH System in study subjects.

NCT ID: NCT03659851 Recruiting - Clinical trials for Left Ventricular Dysfunction

Levosimendan In Patients Undergoing LVAD Implantation

Start date: June 1, 2009
Phase:
Study type: Observational [Patient Registry]

According to the results from the literature, it has been shown that levosimendan usage 24-48 hours before LVAD implementation can improve short and long-term outcome in these patients regarding to the patients without preoperative pretreatment. The aim is to compare short and long-term outcome in patients who underwent to LVAD implementation and pretreated with levosimendan regarding the patient without pretreatment or with other medications.

NCT ID: NCT00733447 Approved for marketing - Clinical trials for Biventricular Failure

SynCardia Freedom Driver System Study

Start date: March 2010
Phase: N/A
Study type: Expanded Access

The purposes of this study are to confirm that the Freedom Driver System is a suitable pneumatic driver for clinically stable TAH-t subjects, and that patients and lay caregivers can be trained to manage the Freedom Driver System safely outside the hospital.

NCT ID: NCT00614510 Completed - Clinical trials for Biventricular Failure

SynCardia CardioWest TAH-t Postmarket Surveillance Study

Start date: August 2006
Phase: N/A
Study type: Observational

The purpose of this study is to demonstrate that the results achieved in the original pivotal clinical investigation of 81 subjects from five clinical sites are generalizable to new clinical sites that complete the staff training defined in the SynCardia Systems, Inc. Training Manual and who enroll subjects who meet the intended use defined in the product Instructions for Use.